A gene not previously associated with breast cancer appears to play a pivotal role in the growth and progression of triple-negative breast cancer.
Interval cancers more likely to be earlier stage, proximal, have lower risk of death
Two studies provide new insight into a germline epidermal growth factor receptor T790M mutation in familial non-small cell lung cancer, and suggest the need for tailored approaches for early detection and treatment.
Continued security of patient data is needed following Microsoft's termination of XP support.
Scientists have moved a step closer to being able to preserve fertility in young boys who undergo chemotherapy and radiation treatments for cancer.
Study shows low utilization of bladder cancer perioperative chemotherapy is associated with a survival benefit in the general population.
Inheriting certain DNA sequences can affect the prognosis of bladder cancer patients, according to a new study.
The quest to improve survival of children with a high-risk brain tumor has led investigators to two drugs already used to treat adults with breast, pancreatic, lung, and other cancers.
Those receiving intervention increased clinical skin exams in the seven months following their education.
A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, according to researchers.
Irregular menstrual cycles may be an early marker of ovarian cancer risk, according to a study presented at the annual meeting of the American Association for Cancer Research.
Increased coffee consumption may reduce hepatocellular carcinoma (HCC) risk across ethnicities, according to a study.
The novel cell cycle inhibitor selective for the cyclin-dependent kinases CDK4 and CDK6 (CDK4/6), LY2835219, shows promise for metastatic breast cancer, according to a study.
A method called molecular subtyping can help doctors better determine which of their breast cancer patients are at high risk of getting breast cancer again, according to a new study.
For head and neck cancer patients undergoing radiation therapy, a reduction in the amount of radiation treatment volume to the submandibular (level IB) lymph nodes resulted in better patient-reported salivary function.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|